Prothena | Betriebsaufwand



Operating Expenses Veränderung Datum
Acadia Pharmaceuticals USD 225.03M 118.93M 2025-03
Agios Pharmaceuticals USD 139.51M 24.16M 2025-06
ALKERMES USD 297.68M 4.96M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amgen USD 6.86B 85M 2025-03
Biogen USD 1.79B 326.1M 2025-06
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Exelixis USD 354.68M 13.9M 2025-07
Incyte USD 904.7M 56.97M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
MacroGenics USD 35.94M 20.58M 2024-12
Neurocrine Biosciences USD 541.9M 7M 2025-06
Prothena USD 67.02M 463K 2024-12
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03
Vertex Pharmaceuticals USD 1.74B 146.9M 2025-03


Prothena Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.